Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance (Q35487439)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Candida glabrata

0 references

People's Republic of China

0 references

invasive candidiasis

1 reference

based on heuristic

inferred from title

Candida parapsilosis

object named as

Candida parapsilosis

1 reference

based on heuristic

inferred from title

object named as

Candida krusei

1 reference

based on heuristic

inferred from title

Candida tropicalis

object named as

Candida tropicalis

1 reference

based on heuristic

inferred from title

15

object named as

Fanrong Kong

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1

object named as

Meng Xiao

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sharon C.-A. Chen

3

object named as

Sharon C-A Chen

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Xin Fan

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

He Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Zi-Yong Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Kang Liao

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Shu-Lan Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Yan Yan

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Mei Kang

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Zhi-Dong Hu

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Yun-Zhuo Chu

11

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Tie-Shi Hu

12

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Yu-Xing Ni

13

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Gui-Ling Zou

14

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Ying-Chun Xu

16

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

3 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

802-810

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Emerging opportunistic yeast infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Epidemiology of opportunistic fungal infections in Latin America.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Invasive candidiasis in intensive care units in China: a multicentre prospective observational study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Epidemiology of invasive mycoses in North America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Active surveillance for candidemia, Australia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Three clustered cases of candidemia caused by Candida quercitrusa and mycological characteristics of this novel species

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candida

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne m

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU460

21 January 2018

Identifiers

10.1093/JAC/DKU460

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35487439&oldid=1970236152"